Alzheimer’s disease (AD) is the commonest cause of dementia worldwide. However, no treatment is yet available to halt or reverse the underlying pathology of established disease. Advances in the management of other common diseases and an improvement in general health have resulted in an increasingly elderly population so that the prevalence of AD is expected to increase significantly over time. In 2015, almost 47 million people worldwide were estimated to be affected by dementia, with estimates of 75 million by 2030, and 131 million by 2050, with the greatest increase expected in low-income and middle-income countries. The socio-economic burden of dementia has become immense and the development of effective interventions has become one of the greatest priorities for health care research in the twenty-first century.